John L. Lubniewski, Chief Business Officer at HTG MOLECULAR DIAGNOSTICS, INC (HTGM), bought 5,000 shares at $7.67 ($38K) on 2015-08-11, disclosed to the SEC on 2015-08-12.
Open-market purchase of $38k HTGM by Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.50 | 14 | $105 | 0.3% |
| 2 | $7.67 | 4,986 | $38K | 99.7% |
| Total | $7.67 avg | 5,000 | $38K | 100% |
| Filing → |
| HTGM | SELL | 2016-03-09 | $11K | — | Filing → |